Drug intelligence / Profile preview

Krozer-Makshi

Development stage
Unknown
Lead developer
Makshi Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Krozer-Makshi is a branded generic formulation of azithromycin, a macrolide antibiotic marketed by Makshi Healthcare. Azithromycin is a broad-spectrum antimicrobial agent that functions by binding to the 50S subunit of the bacterial ribosome, specifically the 23S rRNA, which inhibits the translocation step of protein synthesis and halts bacterial growth. It is widely utilized for the treatment of community-acquired respiratory infections, skin and skin structure infections, and certain sexually transmitted infections such as chlamydia. Krozer-Makshi is typically administered orally and is valued for its high intracellular concentration and prolonged tissue half-life, which allows for convenient once-daily dosing and short treatment durations.

Brand names
Krozer-MakshiKrozer-500Krozer500Krozer 500
Other names
azithromycin
02

Targets

Bacterial 50S ribosomal subunit

Beyond the preview

Go deeper on Krozer-Makshi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Krozer-Makshi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call